Technology ID
              TAB-2664
          T24 Antigen for Diagnosing or Treating Taenia solium Cysticercosis
E-Numbers
          E-237-2013-0
              Lead Inventor
          Hancock, Kathy
              Lead IC
          CDC
              Co-Inventors
          Williams, Fatima
          Yushak, Melinda
          Pattabhi, Sowmya
          Tsang, Victor
              ICs
          CDC
              Applications
          Vaccines
          Therapeutics
          Diagnostics
              Therapeutic Areas
          Rare/Neglected Diseases
          Infectious Disease
              Development Status
              - Early-stage
 - In vitro data available
 
In order to develop a simple detection assay for field use, CDC researchers cloned and sequenced the Taenia solium T24 diagnostic protein. The T24 sequences can be used to detect and diagnose T. solium infection or can be formulated into a pharmaceutical composition. T. solium is a species of tapeworm. Intestinal infection with T. solium is referred to as taeniasis. Many taeniasis infections are asymptomatic but may be characterized by insomnia, anorexia, abdominal pain and weight loss. Cysticercosis infection, which can be fatal, may develop if T. solium larvae migrate out of the intestine and form cysticerci in various body tissues. This technology may be used to develop a diagnostic, vaccine, or therapeutic for infection related to T. solium.
      
  Commercial Applications
              - Vaccine or therapeutic for taeniasis or cysticercosis resulting from T. solium infection
 - Diagnosis of T. solium infection
 - Zoonotic disease research and surveillance
 - Public health monitoring programs
 - Livestock health and food-source monitoring
 
Competitive Advantages
              - Rapid, accurate, sensitive, and safe compared to current radiologic and biopsy diagnostic methods
 - Easy-to-use diagnostic kit that doesn't require abnormal temperatures or specialized equipment
 - Can be developed for serologic and/or nucleic acid diagnostics
 - Cost-effective; useful for developing countries
 
Licensing Contact: